TrialThe Journal of clinical endocrinology and metabolism2020

A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia.

Diala El-Maouche et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.